Assessment of Bioactivity of an
Ethnomedicine: Hyptis suaveolens (L.) Poit
Amit Roy
Columbia
Institute of Pharmacy, Tekari, Raipur (C.G.), India
ABSTRACT:
The work reported in this study is a part of research
project that encompasses pharmacological and phytochemical investigation of
some ethnopharmacologically important plants of
Chhattisgarh- India. Here preliminary work done on Hyptis suaveolens
(L.) Poit. (H. suaveolens), is reported as this plant is being used to treat a wide assortment of
diseases by the local inhabitants of Chhattisgarh. The pharmacological
potential of this plant was evaluated by using some benchtop
bioassay methods like antimicrobial, antioxidant, brine shrimp lethality test
(BSLT) and crown gall tumor assay.
These studies were carried out to screen H. suaveolens for its
bioactivity so that further study can be carried out.
The alcoholic extract of H. suaveolens was fractioned into chloroform
soluble and insoluble fraction and both were subjected for these in vitro
studies. Both the fractions of H. suaveolens methanolic extract were found to
exhibit significant activity in all the bioassay models. The results were
compared with those produced by standards used in each study model
respectively. The present study supports that the bioassay methods are simple
reliable and convenient method for assessment of bioactivity of medicinal
plants and lends support for their use in traditional medicine.
KEYWORDS: Ethnomedicine, Hyptis suaveolens,
bioassay
INTRODUCTION:
Hyptis suaveolens
(L.) Poit. belongs to family Lamiaceae, or the mint family.
They mostly exhibit aromatic or bitter-aromatic, stimulant and astringent
properties. They are used as tonics, emmenagogues,
diaphoretics and antispasmodics. The leaves of many members contain aromatic
essential oils. H. suaveolens is considered to be stimulant, carminative, sudorific and lactagogue and is
used in ethnomedicine as an anticatarrhal,
anticutaneous, parasitic, and as an antipyretic.
Ethnic communities of India use it for headache, to stop bleeding of the nose,
as cure for sores due to fungal infection and in malarial fever. The Lodhas (a tribal community of India) use fresh leaf juice
on cuts and wounds as antiseptic. In Arunachal Pradesh- India the natives use
the plant leaf for itching, cough and cold1-7). Hyptis suaveolens is known as Ganga Tulsi in Chhattisgarh. Here
the traditional healers use leaves externally for treatment of cancerous wound
and the roots of this herb in treatment of indications that resembles brain
tumor. Some healers use this herb in the form of decoction, alone or in
combination with other herbs as carminative, acidity and heartburn along with
number of other problems 8-13.
Many researchers at times only isolate and characterize
a plethora of novel botanically-derived chemical substances without regard to
bioactivities, nevertheless, to achieve applied meaning and significance in
natural product study we need to incorporate bioassays14. The
bioassays offer special advantages for identification of medicinal botanical
extracts15. Here we
have adopted four “bench top” bioassays which do not require higher animals to
screen and direct the fractionation of botanical extracts in drug discovery
efforts. These are: antimicrobial, antioxidant, brine shrimp lethality test
(BSLT) and crown gall tumor assay.
These are general bioassays that are
inexpensive, rapid, technologically simple, animal sparring and require little
technical training. They are capable of detecting a board spectrum of
bioactivity present in crude extracts; BSLT is a general bioassay; the
inhibition of crown gall tumors on discs of potato tubers is an antitumor bioassay,
while antimicrobial activity and antioxidant activity helps to ascertain the
presence of cytotoxicity and any significant
biological activity16-22.
MATERIALS
AND METHODS:
Plant material
The flowering whole plants were collected from the
fields around the campus of Indira Gandhi Krishi Vishvavidyalaya
(Agriculture University), Raipur (Chhattisgarh), India, during the months of
December and January 2004-05, and the identification of plant was done by Prof.
P. Jayaraman, Director Plant Anatomy Research Centre;
Chennai- India. A specimen was vouchered, and
deposited at Institute of Pharmacy, Pt. Ravishankar Shukla Vishvdyalaya, Raipur; Chhattisgarh, India.
Brine shrimps: The brine shrimp eggs were obtained from
Southern Aquaculture, Chennai, India.
Preparation of the extract
One kilogram of powdered drug was packed in soxhlet apparatus and extracted with petroleum ether (60-80âC) to defat the drug. Defatted powdered drug was then extracted
with ethanol (95%). The alcoholic extract thus obtained was further fractioned
with chloroform into chloroform soluble and insoluble fractions. The solvents
were removed by distillation and the last traces of solvent being removed under
reduced pressure. The extracts and fractions were weighed and thereafter, were
stored in refrigerator for further experimental work.
Preparations of dilutions of
crude extract for antibacterial assay
The methods of Akujobi et
al., (2004)23 and Esimone et al., (1998)24 were adopted with minor
modifications. The crude extracts were dissolved in 30% dimethylsulphoxide
(DMSO) and further diluted to obtain 5 mg/ml, 25 mg/ml, 50 mg/ml, 100 mg/ml and
200 mg/ml concentrations. These were stored at 15âC until required.
Disc diffusion antimicrobial
bioassay
The main aim of this assay was to determine if the
plant extract under investigation possess any antibiotic activity. The
antimicrobial assays were performed by minimum inhibitory concentration (MIC)
determination and diffusion disc methods as described earlier24- 27
with modifications.
In-vitro Antioxidant activity
In
our work we have performed some more popular methods that were easy to perform
in our laboratory conditions.
DPPH assay: The method followed here was introduced by Marsden
Blois, more than 50 years ago28. The free radical scavenging
activity of the extracts and butylated hydroxy toluene (BHT) was measured in terms of hydrogen
donating or radical-scavenging ability using the stable radical DPPH29.
H2O2 radical scavenging activity:
The ability of the extracts
to scavenge hydrogen peroxide was determined according to Sundararajan
et al., 200629. A solution
of H2O2 was prepared in phosphate buffer (pH 7.4). H2O2
concentration was determined spectroscopically
measuring absorption with extinct coefficient for H2O2.
Different concentrations of extracts in distilled water were added to a H2O2
solution (0.6 ml, 40 mM). Absorbance of H2O2
at 230 nm was determined 10 min later against a blank solution containing the
phosphate buffer without H2O2. a-tocopherol was
used as the standard. The % of H2O2 scavenging of both
the extracts and standard compound was calculated by the equation:

Where, Acont is the absorbance of the control reaction
and Atest is the absorbance in the
presence of the sample of the extracts.
Determination of reducing power: The reducing power of extracts was
determined according to the method of Rajeshwar, et al., 200530. Various
concentrations of the extracts in 1.0 ml of deionized
water were mixed with phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and 1% potassium
ferricyanide (2.5 ml). The mixture was incubated at
50°C for 20 min. A portion (2.5 ml) of trichloroacetic
acid (10%) was added to the mixture, which was then centrifuged at 3000 rpm for
10 min. The upper layer of the solution (2.5 ml) was mixed with distilled water
(2.5 ml) and FeCl3 (0.5 ml. 0.1%) and the absorbance was measured at 700 nm.
Increased absorbance of the reaction mixture indicated increased reducing
power. Butylated hydroxy
toluene (BHT) was used as a standard31.
Brine shrimp lethality test: A general bioassay that is very useful to
assess the bioactivity of the plant extracts. The procedure described here has
been adapted from previous studies32, 33. Brine shrimps (Artemia salina)
were hatched using brine shrimp eggs in a glass vessel (1L), filled with
sterile artificial seawater (prepared using sea salt 38 g/L and adjusted to pH
8.5 using 1N NaOH) under constant aeration and
artificial light provided for 48 h. After hatching, active nauplii
free from egg shells were collected from brighter portion of the hatching
chamber and used for the assay. Nauplii were drawn
through a glass capillary and placed in each vial containing 4.5 ml of brine
solution and their numbers counted. In each experiment, 0.5 ml. of the plant
extract was added to 4.5 ml of brine solution and maintained at room
temperature for 24 h under the light and surviving larvae were counted.
Experiments were conducted along with control (vehicle treated) and different
concentrations of the test substances in a set of six tubes per dose. The
percentage lethality was determined by comparing the mean surviving larvae of
the test and control tubes and LC50 values were obtained.
Crown gall tumor assay: Goal of scientists over the past years had
been the development and application of crown gall tumor assay as a bench-top
bioassay that is simple enough for phytochemists to
use34. Modification
of this assay was done by McLaughlin to perform a procedure that is rapid,
inexpensive, safe, animal sparing, and a statistically reliable prescreen for in vivo murine
leukemia antitumor activity34,35.
For crown gall tumor assay, the procedure described by Oran47 and Hussain et al. 49 was followed with slight
modification. Using sterile technique, 2 ml of bacterial growth, 0.5 ml of the
sample at different concentrations (replaced by distilled water in the case of
the standard), and 5 ml of distilled water were used to prepare the inoculums. Agrobacterium tumefaciens
were grown on a broth medium that contained 0.5 g sucrose, 0.8 g nutrient
broth, and 0.1 g yeast extract and completed to 100 ml distilled water. After
sterilization in an autoclave for 12 min at 121°C and cooling, a loop
containing Agrobacterium tumefaciens was
added and the mixture was placed in dark for 48 h below 30°C. One and a half
grams of agar were dissolved in 100 ml distilled water. After autoclaving for
15 min, 20 ml of the media were poured in each petri
dish under sterile conditions and cooled. Potatoes were washed with tap water
and soaked in bleach. After taking out of bleach they were cut into cylinders
using a potato borer and put in a tray. The cylinders then were cut into discs,
and 5 discs were placed in each Petri dish. For each sample 2–3 Petri dishes
were used, in addition to those used for control. One drop of the inoculums was
then added on each disc, the dishes then were wrapped with parafilm
strips and kept in the dark at 27°C for 21 days. After 21 days, the discs were
stained with Lugol’s solution (10% KI and 5% I2) for
30 minutes and then observed under dissecting microscope. Numbers of tumors per
disc were counted and percent inhibition for each concentration was determined
by the formula given below.
![]()
Statistical analysis
All the data were subjected to statistical analysis
using SPSS 14.0 for Windows. The statistical analysis was performed by using
one-way analysis-of-variance (ANOVA) followed by Dunnet’s
test for individual comparison of groups with control. p-values <0.05 were
considered as significant. The values are represented as the mean ± SEM for six
sets of observation.
RESULTS AND DISCUSSION:
Disc diffusion antimicrobial
bioassay
The disc
diffusion method was used to determine the inhibition zones of Hyptis suaveolens extract. Results of the disc
diffusion antimicrobial bioassay of the different concentrations of the
extract on the test isolates and the minimum inhibitory concentrations of the
extract on the test isolates are shown in table 1. The results are indicative
of the fact that an increase in concentration of the extracts as well as the
standard drugs results in augmented zone of inhibitions. The extract had
pronounced effect on E. coli with a
ZOI of 48 mm at a concentration of 200 mg/ disc and it was least effective on Shigella sonnei. The
extract had moderate effect on rest of the microorganisms tested. The minimum
inhibitory concentrations were 2.48, 5.61 8.52, 8.34 and 6.13 mg/ml for E.coli, B.subtilis, S.aureus, Shigella sonnei and C.albicans
respectively.
In-vitro Antioxidant activity
DPPH scavenging activity, H2O2
radical scavenging activity and reducing power of the extract at different
concentrations was evaluated to determine its antioxidant potential. The
results of antioxidant activities are shown in table 2, 3 and 4, which
illustrates that the tested extract has a very moderate, but definitive
antioxidant capability in each of the models tested. It has an IC50 value
of 30.06 µg/ ml in DPPH scavenging model compared to 18.92 µg/ml of the
standard, while in H2O2 scavenging model the IC50
was 178.47mg/ml, compared to
129.84mg/ml of α-tocopherol that was used as standard. The extract had a
comparable reducing power to the standard drug BHT (butylated
hydroxy toluene)
Brine shrimp lethality test
The results of BSLT are shown
in table 5. The chloroform
soluble and insoluble fractions at concentration of 10, 25, 50, 100 and 150
µg/ml was tested and showed LD50 values of 43.08 µg/ml and 66.93
µg/ml..
Crown gall tumor assay
Result shows that chloroform
soluble fraction and chloroform insoluble fraction exhibit inhibition of tumors
in potato discs in dose dependent manner and gave LD50 values of 29.71 µg/ml and 74.23 µg/ml respectively (Table 6).
The results of
antimicrobial and antioxidant activities have shown that H. suaveolens extract exhibited both
antibacterial as well as anti fungal activities. It also successfully
illustrated free radical scavenging and reducing abilities.
Table 1: Result of disc diffusion antimicrobial
bioassay
|
ZOI* |
|||||
|
|
E.coli |
B.subtilis |
S.aureus |
Shigella sonnei |
C.albicans |
|
H.
suaveolens extract |
|||||
|
5 mg/disc |
26 |
14 |
8.4 |
3.1 |
12 |
|
25 mg/disc |
31 |
19 |
13 |
8.8 |
17 |
|
50 mg/disc |
35 |
24 |
16 |
12 |
22 |
|
100 mg/disc |
40 |
30 |
22 |
15 |
26 |
|
200 mg/disc |
48 |
36 |
28 |
19 |
33 |
|
MIC (mg/ml) |
2.48 |
5.61 |
8.52 |
8.34 |
6.13 |
|
Ciprofloxacin |
|||||
|
5 µg/disc |
21 |
24 |
17 |
14 |
6.4 |
|
25 µg/disc |
33 |
34 |
27 |
23 |
10 |
|
50 µg/disc |
36 |
39 |
32 |
28 |
13 |
|
100 µg/disc |
42 |
44 |
37 |
32 |
15 |
|
200 µg/disc |
47 |
49 |
44 |
38 |
20 |
|
MIC (µg/ ml) |
2.45 |
2.02 |
3.98 |
4.13 |
7.12 |
|
Ketokonazole |
|||||
|
5 µg/disc |
--- |
16 |
--- |
--- |
15 |
|
25 µg/disc |
--- |
23 |
--- |
--- |
21 |
|
50 µg/disc |
--- |
26 |
--- |
--- |
24 |
|
100 µg/disc |
--- |
31 |
--- |
--- |
27 |
|
200 µg/disc |
--- |
37 |
--- |
--- |
35 |
|
MIC (µg/ ml) |
--- |
3.75 |
--- |
--- |
4.52 |
The results are the mean
values of triplicate tests repeated three times after every 72 hours of
inhibition at 370C and observations p<0.05 were considered
significant. ZOI* zone of inhibition in mm; MIC minimum inhibitory
concentration
Table 2: Result of DPPH scavenging activity
|
Treatment |
10 µg/ml |
20µg/ml |
50 µg/ml |
100 µg/ml |
IC50 |
|
BHT |
28.8±0.22 |
61.8± 0.70 |
79.8± 1.14 |
95.17± 1.45 |
18.92 µg/ml |
|
H. suaveolens |
21.6± 0.19*** |
54.2± 0.71*** |
73.1± 1.01** |
90.5± 1.36* |
30.06 µg/ml |
Data are expressed as mean ±
S.E.M., n = 6; *p<0.01 vs control, ** p< 0.001 vs control and ***p< 0.0001 vs
control by students‘t’
test
Table 3: Result of H2O2 Radical
scavenging
|
Treatment |
50 mg/ml |
100 mg/ml |
200 mg/ml |
300 mg/ml |
350 mg/ml |
IC50 |
|
α- tocopherol |
31.17± 0.48 |
46.33± 0.84 |
67.67± 1.23 |
79.83± 1.58 |
88.67± 2.04 |
129.84mg/ml |
|
Hyptis |
20.52± 0.30*** |
36.67± 1.05*** |
60.17± 1.19*** |
72.17± 1.35** |
81.5± 1.98* |
178.47mg/ml |
Data are expressed as mean ±
S.E.M., n = 6; *p<0.01 vs control, ** p< 0.001 vs control and ***p< 0.0001 vs
control by students‘t’
test
Table 4: Result of reducing Power
|
Treatment |
100mg |
200mg |
500mg |
600mg |
1000mg |
|
BHT |
0.987± 0.02 |
1.25±0.02 |
1.61±0.02 |
1.8±0.05 |
2.28±0.06 |
|
H. suaveolens |
0.92±0.02* |
1.12±0.03** |
1.54± 0.07 |
1.68± 0.02* |
2.16±0.05 |
Data are expressed as mean ± S.E.M., n = 6; *p<0.01 vs control and ** p< 0.001 vs
control by students‘t’
test
Table 5: Brine shrimp
lethality of fractions of H. suaveolens ethanolic extract
|
Treatment |
Percent deaths
at 24 hour |
LD50
mg/ml |
||||
|
10 mg/ml |
25 mg/ml |
50 mg/ml |
100 mg/ml |
150 mg/ml |
||
|
Chloroform
soluble fraction |
20.62 ± 0.20 |
47.59 ±0.30 |
74.50 ± 0.58 |
86.32 ± 0.85 |
93.03 ± 1.06 |
43.08 ±3.68 |
|
Chloroform
insoluble fraction |
17.10 ± 0.15 |
39.02±0.22 |
60.90 ± 0.44 |
70.37 ± 0.64 |
76.75 ± 0.87 |
66.93 ±5.03 |
|
Control (only
solvent) |
0 |
0 |
0 |
0 |
0 |
- |
Data analyzed by one way ANOVA; values are mean ± S.M.E., statistically
significant at p < 0.05; n = 6.
Table 6: Crown gall tumor
assay of fractions of H. suaveolens ethanolic extract
|
Treatment |
Percent
Inhibition |
LD50
mg/ml |
||||
|
10 mg/ml |
20 mg/ml |
30 mg/ml |
40 mg/ml |
50 mg/ml |
||
|
Chloroform
soluble fraction |
19.03 ± 0.29 |
43.62 ± 0.55 |
67.5 ±0.76 |
78.5 ± 0.76 |
85.83 ± 1.42 |
29.71 ± 3.09 |
|
Chloroform
insoluble fraction |
12.05 ± 0.08 |
27.60 ± 0.17 |
42.62 ± 0.31 |
49.25 ± 0.38 |
53.17 ± 0.53 |
74.23 ± 5.15 |
|
Control (only
solvent) |
0 |
0 |
0 |
0 |
0 |
- |
Data analyzed by one way ANOVA; values are mean ± S.M.E., statistically
significant at p < 0.05; n = 6.
These results also show that both the fractions are almost equally
effective against bacteria (both gram positive and gram negative) as well as
fungi; however the chloroform soluble fraction was more effective. The extracts studied in this work showed
significant lethality against brine shrimp and
at the same time appreciable inhibition of tumors in potato discs. This
highlights the fact that the tested extracts have antitumor properties as both
of these assays have been successfully used as simple biological test to guide
the fractionation process of plant extracts in order to detect antitumor
compounds and have good correlation with the human solid tumor cell lines.
CONCLUSION:
In
conclusion the two different extracts of H.
suaveolens have exhibited conclusively the
presence of some interesting biological activities. The results of all these in vitro studies
prove a point that chloroform soluble fraction was more active than chloroform
insoluble fraction. The more active fraction needs to be subjected to thorough
investigation for proving its immense use in traditional medicine.
REFERENCES:
1. Anonymous, 2005. The wealth of India, Raw
materials, Vol. I: A, NISCIR, New Delhi, India, 158-159.
2. Gangrade, S. K., Tripathi,
N. K., Harinkhede, D. K., Mishra,
P. K., 2003. Ethnomedicinal diversity used by tribals of Central India, Sam Com Digital Graphics,
Indore-1, India, 144.
3. Nadkarni, A. K., 2002. Indian Materia
Medica, Vol. 1, Popular prakashan
Pvt. Ltd., Mumbai, India, 84.
4. Kashyap, K., Chand, R. (Eds), 2000. The useful plants of India, National Institute
of Science Communication, CSIR, New Delhi, India, 282.
5. Chopra, R. N., Nayar,
S. L., Chopra, I. C., 1999. Glossary of Indian medicinal plants, National
Institute of Science Communication, CSIR, New Delhi, India, 139.
6. Kirtikar, K. R., Basu, B.
P., 1999. Indian medicinal plants, Vo III, International book distributors, Dehradun, India, 1955-1957, 2032-2033.
7. Rastogi, R. P. (Ed), 1998. Compendium of Indian
medicinal plants Vol II- V, CDRI Lucknow
and NISC New Delhi, India,384; 354-355; 397; 444.
8. Pal, D. C., Jain, S. K., 1998. Tribal
medicine, Naya Prokash, 206
Bidhan Sarani, Calcutta, p.
154.
9. Chatterjee, A, Pakrashi, S.
C., 1997. The treatise of Indian medicinal plants, Vol. V, National Institute
of Science Communication, CSIR, New Delhi, p. 15.
10. Mudgal, V., Khanna,
K. K., Hajra, P. K., (Edts.)
1997. Flora of Madhya Pradesh Vol I, Botanical survey
of India Allahabad, pp. 391, 403-404.
11. Samvatsar, S., 1995. The flora of western tribal
Madhya Pradesh, Scientific Publishers, Jodhpur, p. 238.
12. Srivastava, R. C., 1989. Drug-Plant resources of
Central India (An inventory), Today and Tomorrows Printers and Publishers, New
Delhi, p. 72-73.
13. Oudhia, P. In: www.botanical.com. Accessed on 4th
July, 2004.
14. Jerry, l. M., Lingling,
l. R., 1998. The use of biological assays to evaluate botanicals, Drug Information J. 32, 513–524.
15. Hostettmann, K., Marston, A., 2002. Twenty years of
research into medicinal plants: Results and perspectives, Phytochem. Rev. 1, 275–285.
16. Newman, D. J., Cragg,
G. M., Snader, K. M., 2003. Natural products as
sources of new drugs over the period 1981-2002, J Nat Prod 66, 1022
-1037.
17. Newman, D. J., Cragg,
G. M., Snader, K. M., 2000. The influence of natural
products upon drug discovery, Nat Prod Rep 17, 215-234.
18. Borris', R. P., 1996. Natural products research: perspectives from
a major pharmaceutical company, J. Ethnopharmacol.
51, 29-38.
19. Cragg, G. M., Newman, D. J., 2005. Biodiversity: A continuing source of novel
drug leads, Pure Appl. Chem. 77, 7-24.
20. Cragg, G. M., Newman, D. J., 2001. Natural
product drug discovery in the next millennium, Pharm. Biol. 39, 8-17.
21. Fialho Beatriz de Castro. Biodiversity and
Technological Development: Opportunities for Developing Countries and the Case
of Brazil, Journal of Economic Literature O31, L65, In:
http://bcsia.ksg.harvard.edu/BCSIA_content/documents/fialhob.pdf. Accessed on
17th Aug. 2004.
22. Mclaughlin, J. L., Rogers, L. L., The use of
biological assays to evaluate botanicals, Drug Infor.
J. 32, 513-524.
23. Akujobi, C., Anyanwu, B.
N., Onyeze, C. and Ibekwe,
V. I. (2004). Antibacterial Activities and Preliminary Phytochemical Screening
of Four Medicinal Plants. Journal of Applied Sciences. 7(3); 4328 – 4338.
24. Esimone, C. O., Adiukwu,
M. U. and Okonta, J. M. (1998). Preliminary
Antimicrobial Screening of the Ethanolic Extract from the Lichen Usnea subfloridans (L).
Journal of Pharmaceutical Research and Development. 3(2); 99 – 102.
25. Brasileiro, G., Pizziolo,
V.R., Raslan, D.S., Jamal, C.M., Silveira,
D., 2006. Antimicrobial and cytotoxic activities
screening of some Brazilian medicinal plants used in Governador Valadares
district Beatriz. Brazilian Journal of Pharmaceutical Sciences 42, 195-202
26. Osadebe, P. O. and Ukwueze,
S. E. (2004). A Comparative Study of the Phytochemical and Antimicrobial
Properties of the Eastern Nigerian Species of African Mistletoe (Loranthus micranthus)
sourced from different host trees. Journal of Biological Research and
Biotechnology. 2(1); 18 – 23.
27.
Digrak, M., Ahmet., Alma, I.M.H., Sen, S. 1999. Antimicrobial Activities of the Extracts of
Various Plants (valex, mimosa bark, gallnut powders,
Salvia sp. and Phlomis sp.) Tr. J. of Biology 23,
241-248
28.
Prakash, A., Antioxidant activity, In:
http://www.terranostrachocolate.com/files/Comparative_and_General_Antioxidant_Information.pdf
29. Sundararajan, R., Haja, N. A.,
Venkatesan, K., Mukherjee,
K., Saha, B.
P., Bandyopadhyay,
A. and Mukherjee, P. K., 2006. Cytisus scoparius link - A natural antioxidant. BMC Complementary
and Alternative Medicine 6; In: http://www.biomedcentral.com/1472-6882/6/8
30. Rajeshwar, Y., Kumar, G.P.S., Gupta, M., Mazumder, U.K., 2005. Studies on in vitro antioxidant activities of methanol extract of Mucuna pruriens (Fabaceae) seeds. European Bulletin of Drug Research 13 (1),
31-39
31. Benkeblia, N., 2005. Free-radical scavenging
capacity and antioxidant properties of some selected onions (Allium cepa L.) and
garlic (Allium sativum
L.) extracts, Brazilian Archives of Biology and Technology 48, 753-759.
32. Krishnarajua, A. V., Raoa T.
V. N., Sundararajua, D., Vanisreeb,
M., Tsayb, H., Subbarajua,
G. V., 2005. Assessment of bioactivity of Indian medicinal plants using brine
shrimp (Artemia salina)
lethality assay, International J Applied Sci. Eng. 3, 125-134.
33. Finney, D. J., 1971. Probit
Analysis (3rd Ed), University Press. Cambridge, pp. 37-77.
34. Sawsan, A., 1999. Potato disc bioassay for some
Jordanian medicinal plants, Oran Pharm. Biol. 37,296-299.
35.
Hussain, L.A., Zia M., Mirza, B., 2007. Cytotoxicity and antitumor potential of Fagonia cretica, Turk J Biol
31, 19-24.
Received on 09.11.2011
Modified on 08.12.2011
Accepted on 25.12.2011
© A&V Publication all right reserved
Research J.
Science and Tech. 4(1): Jan.-Feb. 2012: 1-5